Hysterectomy-corrected uterine corpus cancer incidence trends and differences in relative survival reveal racial disparities and rising rates of nonendometrioid cancers

Journal of Clinical Oncology

Volumn 37, Issue 22, 2019, Pages 1895-1908

  Clarke, Megan A ^a   Devesa, Susan S ^a   Harvey, Summer V ^a   Wentzensen, Nicolas ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ASIAN; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; BLACK PERSON; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CAUCASIAN; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CARCINOMA; ETHNIC DIFFERENCE; ETHNICITY; FEMALE; HISPANIC; HISTOLOGY; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; PACIFIC ISLANDER; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; SURVIVAL RATE; UTERUS CANCER; UTERUS SARCOMA; ADENOCARCINOMA; AFRICAN AMERICAN; CANCER REGISTRY; CARCINOMA; ETHNIC GROUP; ETHNOLOGY; GEOGRAPHY; HEALTH DISPARITY; INCIDENCE; MIDDLE AGED; REGISTER; RISK FACTOR; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR INVASION; UNITED STATES; UTERUS;

ADENOCARCINOMA; ADULT; AFRICAN AMERICANS; AGED; CARCINOMA; ETHNIC GROUPS; FEMALE; GEOGRAPHY; HEALTH STATUS DISPARITIES; HUMANS; HYSTERECTOMY; INCIDENCE; MIDDLE AGED; NEOPLASM INVASIVENESS; PREVALENCE; REGISTRIES; RISK FACTORS; SEER PROGRAM; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES; UTERINE NEOPLASMS; UTERUS;

EID: 85070214985     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.19.00151     Document Type: Article

References (40)

1. Siegel RL, Miller KD, Jemal A: Cancer statistics, 2018. CA Cancer J Clin 68:7-30, 2018
2. Lortet-Tieulent J, Ferlay J, Bray F, et al: International patterns and trends in endometrial cancer incidence, 1978-2013. J Natl Cancer Inst 110:354-361, 2018
3. Rahib L, Smith BD, Aizenberg R, et al: Projecting cancer incidence and deaths to 2030: The unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 74:2913-2921, 2014
4. Sheikh MA, Althouse AD, Freese KE, et al: USA endometrial cancer projections to 2030: Should we be concerned? Future Oncol 10:2561-2568, 2014
5. Wartko P, Sherman ME, Yang HP, et al: Recent changes in endometrial cancer trends among menopausal-age U.S. women. Cancer Epidemiol 37:374-377, 2013
6. Suarez AA, Felix AS, Cohn DE: Bokhman Redux: Endometrial cancer “types” in the 21st century. Gynecol Oncol 144:243-249, 2017
7. Felix AS, Brinton LA: Cancer progress and priorities: Uterine cancer. Cancer Epidemiol Biomarkers Prev 27:985-994, 2018
8. Cote ML, Ruterbusch JJ, Olson SH, et al: The growing burden of endometrial cancer: A major racial disparity affecting black women. Cancer Epidemiol Biomarkers Prev 24:1407-1415, 2015
9. Long B, Liu FW, Bristow RE: Disparities in uterine cancer epidemiology, treatment, and survival among African Americans in the United States. Gynecol Oncol 130:652-659, 2013
10. Tarney CM, Tian C, Wang G, et al: Impact of age at diagnosis on racial disparities in endometrial cancer patients. Gynecol Oncol 149:12-21, 2018
11. Henley SJ, Miller JW, Dowling NF, et al: Uterine cancer incidence and mortality: United States, 1999-2016. MMWR Morb Mortal Wkly Rep 67:1333-1338, 2018
12. Hosh M, Antar S, Nazzal A, et al: Uterine sarcoma: Analysis of 13,089 cases based on Surveillance, Epidemiology, and End Results database. Int J Gynecol Cancer 26:1098-1104, 2016
13. Jamison PM, Noone AM, Ries LA, et al: Trends in endometrial cancer incidence by race and histology with a correction for the prevalence of hysterectomy, SEER 1992 to 2008. Cancer Epidemiol Biomarkers Prev 22:233-241, 2013
14. Sherman ME, Carreon JD, Lacey JV Jr, et al: Impact of hysterectomy on endometrial carcinoma rates in the United States. J Natl Cancer Inst 97:1700-1702, 2005
15. Temkin SM, Kohn EC, Penberthy L, et al: Hysterectomy-corrected rates of endometrial cancer among women younger than age 50 in the United States. Cancer Causes Control 29:427-433, 2018
16. Siegel RL, Devesa SS, Cokkinides V, et al: State-level uterine corpus cancer incidence rates corrected for hysterectomy prevalence, 2004 to 2008. Cancer Epidemiol Biomarkers Prev 22:25-31, 2013
17. Mariotto AB, Zou Z, Johnson CJ, et al: Geographical, racial and socio-economic variation in life expectancy in the US and their impact on cancer relative survival. PLoS One 13:e0201034, 2018
18. National Cancer Institute: Surveillance, Epidemiology, and End Results Program: SEER*Stat Databases—Incidence: SEER18 Regs research data, Nov 2017 sub (2000-2015),Katrina/Rita population adjustment.. https://seer.cancer.gov/data-software/documentation/seerstat/nov2017/
19. National Cancer Institute: Surveillance, Epidemiology, and End Results Program: Race recode changes for the 1973-2005 SEER research data (November 2007 submission) and later releases. https://seer.cancer.gov/seerstat/variables/seer/race_ethnicity/
20. Centers for Disease Control and Prevention: Behavioral Risk Factor Surveillance System: Annual survey data. https://www.cdc.gov/brfss/annual_data/annual_data.htm
21. Kim HJ, Fay MP, Feuer EJ, et al: Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 19:335-351, 2000 22. Devesa SS, Donaldson J, Fears T: Graphical presentation of trends in rates. Am J Epidemiol 141:300-304, 1995
22. Cho H, Howlader N, Mariotto AB, et al: Surveillance Research Program, NCI, Technical Report #2011-01: Estimating relative survival for cancer patients from the SEER program using expected rates based on Ederer I versus Ederer II method. https://surveillance.cancer.gov/reports/tech2011.01.pdf
23. Olson SH, Atoria CL, Cote ML, et al: The impact of race and comorbidity on survival in endometrial cancer. Cancer Epidemiol Biomarkers Prev 21:753-760, 2012
24. Sherman ME, Devesa SS: Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus. Cancer 98:176-186, 2003
25. Baskovic M, Lichtensztajn DY, Nguyen T, et al: Racial disparities in outcomes for high-grade uterine cancer: A California cancer registry study. Cancer Med 7: 4485-4495, 2018
26. Randall TC, Armstrong K: Differences in treatment and outcome between African-American and white women with endometrial cancer. J Clin Oncol 21: 4200-4206, 2003
27. Faber MT, Frederiksen K, Jensen A, et al: Time trends in the incidence of hysterectomy-corrected overall, type 1 and type 2 endometrial cancer in Denmark 1978-2014. Gynecol Oncol 146:359-367, 2017
28. Setiawan VW, Yang HP, Pike MC, et al: Type I and II endometrial cancers: Have they different risk factors? J Clin Oncol 31:2607-2618, 2013
29. Aguilar M, Bhuket T, Torres S, et al: Prevalence of the metabolic syndrome in the United States, 2003-2012. JAMA 313:1973-1974, 2015
30. Hales CM, Carroll MD, Fryar CD, et al: Prevalence of obesity among adults and youth: United States, 2015-2016. NCHS Data Brief 288:1-8, 2017
31. Geiss LS, Wang J, Cheng YJ, et al: Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 years, United States, 1980-2012. JAMA 312:1218-1226, 2014
32. Ye J, Rust G, Baltrus P, et al: Cardiovascular risk factors among Asian Americans: Results from a National Health Survey. Ann Epidemiol 19:718-723, 2009
33. Lee JW, Brancati FL, Yeh HC: Trends in the prevalence of type 2 diabetes in Asians versus whites: Results from the United States National Health Interview Survey, 1997-2008. Diabetes Care 34:353-357, 2011
34. Rodriguez AM, Schmeler KM, Kuo YF: Disparities in endometrial cancer outcomes between non-Hispanic white and Hispanic women. Gynecol Oncol 135: 525-533, 2014
35. Bregar AJ, Alejandro Rauh-Hain J, Spencer R, et al: Disparities in receipt of care for high-grade endometrial cancer: A National Cancer Data Base analysis. Gynecol Oncol 145:114-121, 2017
36. Mahdi H, Hou H, Kowk LL, et al: Type II endometrial cancer in Hispanic women: Tumor characteristics, treatment and survival compared to non-Hispanic white women. Gynecol Oncol 133:512-517, 2014
37. Malagon-Blackwell EM, Seagle BL, Nieves-Neira W, et al: The Hispanic paradox in endometrial cancer: A National Cancer Database study. Gynecol Oncol 146: 351-358, 2017
38. Cook LS, Nelson HE, Cockburn M, et al: Comorbidities and endometrial cancer survival in Hispanics and non-Hispanic whites. Cancer Causes Control 24: 61-69, 2013
39. Pierannunzi C, Hu SS, Balluz L: A systematic review of publications assessing reliability and validity of the Behavioral Risk Factor Surveillance System (BRFSS), 2004-2011. BMC Med Res Methodol 13:49, 2013
40. Polite BN, Adams-Campbell LL, Brawley OW, et al: Charting the future of cancer health disparities research: A position statement from the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute. J Clin Oncol 35:3075-3082, 2017